• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009 - 2017年欧盟地区入住重症监护病房的流感患者死亡结局的影响因素

Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009-2017.

作者信息

Adlhoch Cornelia, Gomes Dias Joana, Bonmarin Isabelle, Hubert Bruno, Larrauri Amparo, Oliva Domínguez Jesús A, Delgado-Sanz Concepción, Brytting Mia, Carnahan Annasara, Popovici Odette, Lupulescu Emilia, O'Donnell Joan, Domegan Lisa, Van Gageldonk-Lafeber Arianne B, Meijer Adam, Kynčl Jan, Slezák Pavel, Guiomar Raquel, Orta Gomes Carlos M, Popow-Kraupp Theresia, Mikas Ján, Staroňová Edita, Melillo Jackie M, Melillo Tanya, Ikonen Niina, Lyytikäinen Outi, Snacken René, Penttinen Pasi

机构信息

Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.

Bruno Hubert, Santé Public France, Saint-Maurice Cedex, France.

出版信息

Open Forum Infect Dis. 2019 Oct 29;6(11):ofz462. doi: 10.1093/ofid/ofz462. eCollection 2019 Nov.

DOI:10.1093/ofid/ofz462
PMID:32258201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7105050/
Abstract

BACKGROUND

Morbidity, severity, and mortality associated with annual influenza epidemics are of public health concern. We analyzed surveillance data on hospitalized laboratory-confirmed influenza cases admitted to intensive care units to identify common determinants for fatal outcome and inform and target public health prevention strategies, including risk communication.

METHODS

We performed a descriptive analysis and used Poisson regression models with robust variance to estimate the association of age, sex, virus (sub)type, and underlying medical condition with fatal outcome using European Union data from 2009 to 2017.

RESULTS

Of 13 368 cases included in the basic dataset, 2806 (21%) were fatal. Age ≥40 years and infection with influenza A virus were associated with fatal outcome. Of 5886 cases with known underlying medical conditions and virus A subtype included in a more detailed analysis, 1349 (23%) were fatal. Influenza virus A(H1N1)pdm09 or A(H3N2) infection, age ≥60 years, cancer, human immunodeficiency virus infection and/or other immune deficiency, and heart, kidney, and liver disease were associated with fatal outcome; the risk of death was lower for patients with chronic lung disease and for pregnant women.

CONCLUSIONS

This study re-emphasises the importance of preventing influenza in the elderly and tailoring strategies to risk groups with underlying medical conditions.

摘要

背景

每年流感流行所带来的发病率、严重程度和死亡率是公共卫生关注的问题。我们分析了重症监护病房收治的实验室确诊流感住院病例的监测数据,以确定导致致命结局的常见决定因素,并为公共卫生预防策略(包括风险沟通)提供信息并确定目标人群。

方法

我们进行了描述性分析,并使用具有稳健方差的泊松回归模型,利用2009年至2017年的欧盟数据估计年龄、性别、病毒(亚)型和基础疾病与致命结局之间的关联。

结果

在基础数据集中纳入的13368例病例中,2806例(21%)死亡。年龄≥40岁和感染甲型流感病毒与致命结局相关。在更详细分析中纳入的5886例已知基础疾病和甲型病毒亚型的病例中,1349例(23%)死亡。甲型H1N1pdm09或甲型H3N2流感病毒感染、年龄≥60岁、癌症、人类免疫缺陷病毒感染和/或其他免疫缺陷以及心、肾和肝脏疾病与致命结局相关;慢性肺病患者和孕妇的死亡风险较低。

结论

本研究再次强调了预防老年人流感以及针对有基础疾病的风险人群制定策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/7105050/b8a6f6463ed2/ofz462f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/7105050/b8a6f6463ed2/ofz462f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceff/7105050/b8a6f6463ed2/ofz462f0001.jpg

相似文献

1
Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009-2017.2009 - 2017年欧盟地区入住重症监护病房的流感患者死亡结局的影响因素
Open Forum Infect Dis. 2019 Oct 29;6(11):ofz462. doi: 10.1093/ofid/ofz462. eCollection 2019 Nov.
2
Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015-2017).在越南,急性呼吸道感染住院成人中检测到的呼吸道微生物:甲型 H1N1pdm09 流感病毒与重症监护病房入院或死亡结局的关系(2015-2017 年)。
BMC Infect Dis. 2021 Apr 6;21(1):320. doi: 10.1186/s12879-021-05988-x.
3
Association between type-specific influenza circulation and incidence of severe laboratory-confirmed cases; which subtype is the most virulent?特定类型流感循环与严重实验室确诊病例发生率之间的关联;哪种亚型毒性最强?
Clin Microbiol Infect. 2020 Jul;26(7):922-927. doi: 10.1016/j.cmi.2019.11.018. Epub 2019 Nov 22.
4
Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.2010-2011 流感季节因实验室确诊流感而住院的患者:按病毒类型和亚型探讨疾病严重程度。
J Infect Dis. 2013 Oct 15;208(8):1305-14. doi: 10.1093/infdis/jit316. Epub 2013 Jul 17.
5
2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.2009-2010 年摩洛哥的 2009 年甲型 H1N1 流感病毒:流行病学、传染性以及与死亡病例相关的因素。
J Infect Dis. 2012 Dec 15;206 Suppl 1(Suppl 1):S94-100. doi: 10.1093/infdis/jis547.
6
A comparison of epidemiology and clinical outcomes between influenza A H1N1pdm09 and H3N2 based on multicenter surveillance from 2014 to 2018 in South Korea.基于韩国 2014 至 2018 年多中心监测的甲型 H1N1pdm09 和 H3N2 流感的流行病学和临床结局比较。
Influenza Other Respir Viruses. 2021 Jan;15(1):99-109. doi: 10.1111/irv.12795. Epub 2020 Aug 25.
7
Clinical features, treatments and outcomes of influenza A (H1N1) 2009 among the hospitalized patients in the clinic for infectious diseases in Novi Sad.诺维萨德传染病诊所住院患者中2009年甲型H1N1流感的临床特征、治疗方法及结果
Vojnosanit Pregl. 2013 Feb;70(2):155-62. doi: 10.2298/vsp1302155c.
8
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.在一个同时流行三种流感病毒型/亚型的季节里,对欧洲流感疫苗有效性的评估:I-MOVE 多中心病例对照研究,2012/13 年流感季节。
Euro Surveill. 2014 Feb 13;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701.
9
Analysis of fatal outcomes from influenza A(H1N1)pdm09 in Mongolia.蒙古甲型H1N1流感大流行的死亡结果分析
Western Pac Surveill Response J. 2012 Aug 31;3(3):43-8. doi: 10.5365/WPSAR.2010.1.1.006. Print 2012 Jul.
10
Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09.甲型H1N1流感大流行病例出现严重后果的危险因素。
Bratisl Lek Listy. 2015;116(6):389-93. doi: 10.4149/bll_2015_074.

引用本文的文献

1
Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV.一种用于同时检测新型冠状病毒2型、甲型/乙型流感病毒和呼吸道合胞病毒的多重实时逆转录聚合酶链反应试剂盒的分析性能评估
PeerJ. 2025 Jul 30;13:e19693. doi: 10.7717/peerj.19693. eCollection 2025.
2
Patients with influenza admitted to a tertiary-care hospital in Riyadh between 2018 and 2022: characteristics, outcomes and factors associated with ICU admission and mortality.2018 年至 2022 年期间,利雅得一家三级保健医院收治的流感患者:特征、结局以及与 ICU 收治和死亡相关的因素。
BMC Pulm Med. 2024 Sep 19;24(1):464. doi: 10.1186/s12890-024-03281-6.
3

本文引用的文献

1
Underdiagnosis of Influenza Virus Infection in Hospitalized Older Adults.老年人住院患者中流感病毒感染的漏诊。
J Am Geriatr Soc. 2018 Mar;66(3):467-472. doi: 10.1111/jgs.15298. Epub 2018 Feb 13.
2
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
3
Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis.
Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases.
流感疫苗接种和早期抗病毒治疗对降低重症流感病例肺炎风险的有效性。
Vaccines (Basel). 2024 Feb 7;12(2):173. doi: 10.3390/vaccines12020173.
4
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.神经氨酸酶抑制剂(奥司他韦)治疗对 11 个欧盟国家 2010 至 2020 年住院流感患者结局的影响:监测数据。
Euro Surveill. 2023 Jan;28(4). doi: 10.2807/1560-7917.ES.2023.28.4.2200340.
5
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment.《意大利老年人用新型四价佐剂流感疫苗:卫生技术评估》。
Int J Environ Res Public Health. 2022 Mar 31;19(7):4166. doi: 10.3390/ijerph19074166.
6
A systematic review and meta-analysis of host genetic factors associated with influenza severity.一项与流感严重程度相关的宿主遗传因素的系统评价和荟萃分析。
BMC Genomics. 2021 Dec 20;22(1):912. doi: 10.1186/s12864-021-08240-7.
7
Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.髓系蛋白酶激活受体-2 促进小鼠流感病毒病理学。
Front Immunol. 2021 Dec 1;12:791017. doi: 10.3389/fimmu.2021.791017. eCollection 2021.
8
Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season.西班牙加泰罗尼亚地区 2017-2018 年流感季住院严重流感病例的结局变量表现
Sci Rep. 2021 Jun 30;11(1):13587. doi: 10.1038/s41598-021-92895-5.
9
Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection.差异的肥大细胞反应在流感病毒感染期间调节抗病毒免疫。
Front Cell Infect Microbiol. 2021 Feb 19;11:580679. doi: 10.3389/fcimb.2021.580679. eCollection 2021.
10
Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial.慢性肾脏病患者单剂量与一剂次加强三价灭活流感疫苗免疫原性和安全性的比较:一项20周开放标签试验
Vaccines (Basel). 2021 Feb 25;9(3):192. doi: 10.3390/vaccines9030192.
高、中、低收入国家与流感相关疾病严重结局相关的风险因素:系统文献回顾和荟萃分析。
Influenza Other Respir Viruses. 2018 Jan;12(1):22-29. doi: 10.1111/irv.12504. Epub 2017 Dec 2.
4
Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.2016年12月至2017年2月欧洲全因和流感所致的超额死亡率
Euro Surveill. 2017 Apr 6;22(14). doi: 10.2807/1560-7917.ES.2017.22.14.30506.
5
Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons.法国重症监护病房流感感染监测:2009/10 年大流行及随后的三个季节。
Euro Surveill. 2015;20(46). doi: 10.2807/1560-7917.ES.2015.20.46.30066.
6
A systematic review of the social and economic burden of influenza in low- and middle-income countries.对低收入和中等收入国家流感的社会经济负担的系统评价。
Vaccine. 2015 Nov 27;33(48):6537-44. doi: 10.1016/j.vaccine.2015.10.066. Epub 2015 Oct 25.
7
New developments of influenza surveillance in Europe.欧洲流感监测的新进展。
Euro Surveill. 2015 Jan 29;20(4):21020. doi: 10.2807/ese.20.04.21020-en.
8
Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases.世界卫生组织欧洲区域医院中严重急性呼吸道感染(SARI)监测——流感阳性SARI病例严重结局危险因素的探索性分析
BMC Infect Dis. 2015 Jan 8;15:1. doi: 10.1186/s12879-014-0722-x.
9
Antiviral combinations for severe influenza.用于重症流感的抗病毒联合疗法。
Lancet Infect Dis. 2014 Dec;14(12):1259-70. doi: 10.1016/S1473-3099(14)70821-7. Epub 2014 Sep 8.
10
Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety.HIV 感染者的流感疫苗接种:系统评价和与疫苗疗效、效果和安全性相关证据质量的评估。
Vaccine. 2014 Sep 29;32(43):5585-92. doi: 10.1016/j.vaccine.2014.07.101. Epub 2014 Aug 12.